Arama Sonuçları - Sue Haupt

Sonuçları Daraltın
  1. 1
    Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways

    Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways Yazar: Sue Haupt, Dinesh Raghu, Ygal Haupt

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Neglecting sex and gender in research is a public-health risk

    Neglecting sex and gender in research is a public-health risk Yazar: Sue Haupt, Cheryl Carcel, Robyn Norton

    Baskı/Yayın Bilgisi 2024
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Regulation of Mutant p53 Protein Expression

    Regulation of Mutant p53 Protein Expression Yazar: Reshma Vijayakumaran, Kah Hin Tan, Panimaya Jeffreena Miranda, Sue Haupt, Ygal Haupt

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Sex disparities matter in cancer development and therapy

    Sex disparities matter in cancer development and therapy Yazar: Sue Haupt, Franco Caramia, Sabra L. Klein, Joshua B. Rubin, Ygal Haupt

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  5. 5
    The role of MDM2 and MDM4 in breast cancer development and prevention

    The role of MDM2 and MDM4 in breast cancer development and prevention Yazar: Sue Haupt, Reshma Vijayakumaran, Panimaya Jeffreena Miranda, Andrew Burgess, Elgene Lim, Ygal Haupt

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  6. 6
    The long and the short of it: the MDM4 tail so far

    The long and the short of it: the MDM4 tail so far Yazar: Sue Haupt, Javier Octavio Mejía-Hernández, Reshma Vijayakumaran, Simon P. Keam, Ygal Haupt

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Clinical Overview of MDM2/X-Targeted Therapies

    Clinical Overview of MDM2/X-Targeted Therapies Yazar: Andrew Burgess, Kee Ming Chia, Sue Haupt, David M. Thomas, Ygal Haupt, Elgene Lim

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  8. 8
    P53: A Guardian of Immunity Becomes Its Saboteur through Mutation

    P53: A Guardian of Immunity Becomes Its Saboteur through Mutation Yazar: Arjelle Decasa Agupitan, Paul J. Neeson, Scott Williams, Jason Howitt, Sue Haupt, Ygal Haupt

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  9. 9
    The power—and complexity—of policy to drive advances in women’s health

    The power—and complexity—of policy to drive advances in women’s health Yazar: Bronwyn M. Graham, Cara Tannenbaum, Alice Witt, Keziah Bennett‐Brook, Sue Haupt, Kate Womersley, Séverine Lamon, Robyn Norton

    Baskı/Yayın Bilgisi 2025
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network

    Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network Yazar: Sue Haupt, Franco Caramia, Alan Herschtal, Thierry Soussi, Guillermina Lozano, Hu Chen, Han Liang, Terence P. Speed, Ygal Haupt

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival

    TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival Yazar: Donald Freudenstein, Cassandra Litchfield, Franco Caramia, Gavin Wright, Benjamin Solomon, David Ball, Simon P. Keam, Paul J. Neeson, Ygal Haupt, Sue Haupt

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis

    Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis Yazar: Shashank Masaldan, S Clatworthy, Cristina Gamell, Peter M. Meggyesy, Antonia-Tonia Rigopoulos, Sue Haupt, Ygal Haupt, Delphine Denoyer, Paul A. Adlard, Ashley I. Bush, Michael A. Cater

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    E6AP promotes the degradation of the PML tumor suppressor

    E6AP promotes the degradation of the PML tumor suppressor Yazar: Igal Louria‐Hayon, Osnat Alsheich-Bartok, Yaara Levav-Cohen, Isabelle Silberman, Michael Berger, Thomas W. Grossman, Konstantin Matentzoglu, Y-H Jiang, Stefan Müller, Martin Scheffner, Sue Haupt, Ygal Haupt

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma

    APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma Yazar: David SH Liu, Matthew Read, Carleen Cullinane, Walid J. Azar, Christina M. Fennell, Karen G. Montgomery, Sue Haupt, Ygal Haupt, Klas G. Wiman, Cuong Duong, Nicholas J. Clemons, Wayne A. Phillips

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than<i>TP53</i>Mutation Status

    SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than<i>TP53</i>Mutation Status Yazar: Kenji M. Fujihara, Mariana Corrales Benitez, Carlos S. Cabalag, Bonnie Z. Zhang, Hyun Soo Ko, David S. Liu, Kaylene J. Simpson, Ygal Haupt, Lara Lipton, Sue Haupt, Wayne A. Phillips, Nicholas J. Clemons

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Role of p53 in the progression of gastric cancer

    Role of p53 in the progression of gastric cancer Yazar: Rita A. Busuttil, Giada V. Zapparoli, Sue Haupt, Christina M. Fennell, Stephen Q. Wong, Jia‐Min Pang, Elena A. Takeno, Catherine Mitchell, Natasha Di Costanzo, Stephen B. Fox, Ygal Haupt, Alexander Dobrovic, Alex Boussioutas

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer

    MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer Yazar: Neil Portman, Heloisa Milioli, Sarah Alexandrou, Rhiannon Coulson, Aliza Yong, Kristine J. Fernandez, Kee Ming Chia, Ensar Halilovic, Davendra Segara, Andrew Parker, Sue Haupt, Ygal Haupt, Wayne D. Tilley, Alexander Swarbrick, C. Elizabeth Caldon, Elgene Lim

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities

    Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities Yazar: Madhu Kollareddy, Elizabeth Dimitrova, Krishna C. Vallabhaneni, Adriano Chan, Thuc Le, Krishna M. Chauhan, Zunamys I. Carrero, Gopalakrishnan Ramakrishnan, Kounosuke Watabe, Ygal Haupt, Sue Haupt, Radhika Pochampally, Gerry R. Boss, Damián G. Romero, Caius G. Radu, Luis A. Martinez

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation

    Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation Yazar: David S. Liu, Cuong Duong, Sue Haupt, Karen G. Montgomery, Colin M. House, Walid J. Azar, Helen Pearson, Oliver M. Fisher, Matthew Read, Glen R. Guerra, Ygal Haupt, Carleen Cullinane, Klas G. Wiman, Lars Abrahmsén, Wayne A. Phillips, Nicholas J. Clemons

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot

    High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot Yazar: Simon P. Keam, Heloise M. Halse, Thu Quynh Nguyen, Minyu Wang, Nicolas Van Kooten Losio, Catherine Mitchell, Franco Caramia, David J. Byrne, Sue Haupt, Georgina L. Ryland, Phillip K. Darcy, Shahneen Sandhu, Piers Blombery, Ygal Haupt, Scott Williams, Paul J. Neeson

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: